Annexon, Inc. (NASDAQ:ANNX – Get Free Report)’s stock price was up 11.9% during trading on Wednesday . The company traded as high as $6.11 and last traded at $6.11. Approximately 587,505 shares traded hands during mid-day trading, a decline of 73% from the average daily volume of 2,187,764 shares. The stock had previously closed at […]
Bain Capital Life Sciences Investors LLC grew its position in shares of Annexon, Inc. (NASDAQ:ANNX – Free Report) by 41.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,061,719 shares of the company’s stock after buying an additional 2,359,793 shares during the period. […]
Bain Capital Life Sciences Investors LLC grew its position in shares of Annexon, Inc. (NASDAQ:ANNX – Free Report) by 41.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,061,719 shares of the company’s stock after buying an additional 2,359,793 shares during the period. […]
BRISBANE, Calif., June 04, 2024 (GLOBE NEWSWIRE) Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of.
BRISBANE, Calif., June 04, 2024 Annexon, Inc. , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical.